They also demonstrated that glutamine metabolism, through its ability to support both mitochondrial function and cellular redox metabolism, becomes a metabolic dependency of FLT3-ITD AML, specifically unmasked by FLT3-TKI treatment [143]. The gene discussed is FLT3; the disease is acute myeloid leukemia.